These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1377170)

  • 21. Two different maturational stages of natural killer lymphocytes in human newborn infants.
    Sancho L; de la Hera A; Casas J; Vaquer S; Martínez C; Alvarez-Mon M
    J Pediatr; 1991 Sep; 119(3):446-54. PubMed ID: 1715396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different sensitivity to interleukin 4 of interleukin 2- and interferon alpha-induced CD69 antigen expression in human resting NK cells and CD3+, CD4-, CD8- lymphocytes.
    Gerosa F; Tommasi M; Carra G; Gandini G; Tridente G; Benati C
    Cell Immunol; 1992 May; 141(2):342-51. PubMed ID: 1533569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of CD56 and HLA/DR antigens in CD2+ cells from multiple myeloma patients.
    Lapeña P; Prieto A; Garcia-Suarez J; Reyes E; San Miguel J; Jorda J; Alvarez-Mon M
    Am J Hematol; 1994 Jun; 46(2):158-9. PubMed ID: 7513496
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.
    Ortaldo JR; Winkler-Pickett RT; Yagita H; Young HA
    Cell Immunol; 1991 Sep; 136(2):486-95. PubMed ID: 1714795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins.
    Phillips JH; Hori T; Nagler A; Bhat N; Spits H; Lanier LL
    J Exp Med; 1992 Apr; 175(4):1055-66. PubMed ID: 1372642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-1 and IL-4 as reciprocal regulators of IL-2 induced lymphocyte cytotoxicity.
    Ebina N; Gallardo D; Shau H; Golub SH
    Br J Cancer; 1990 Oct; 62(4):619-23. PubMed ID: 1699593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of a functional c-kit receptor on a subset of natural killer cells.
    Matos ME; Schnier GS; Beecher MS; Ashman LK; William DE; Caligiuri MA
    J Exp Med; 1993 Sep; 178(3):1079-84. PubMed ID: 7688785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic origin of human natural killer (NK) cells: generation from immature progenitors.
    Silva MR; Kessler S; Ascensao JL
    Pathobiology; 1993; 61(5-6):247-55. PubMed ID: 7507682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of lymphokine-activated killer activity in T-replete and T-cell-depleted human bone marrow by interleukin 4.
    Drobyski WR; LeFever AV; Truitt RL
    Exp Hematol; 1991 Oct; 19(9):950-7. PubMed ID: 1716592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased intercellular adhesion molecule-1 (CD54) and L-selectin (CD62L) expression on peripheral blood natural killer cells in asthmatic children with acute exacerbation.
    Lin SJ; Chang LY; Yan DC; Huang YJ; Lin TJ; Lin TY
    Allergy; 2003 Jan; 58(1):67-71. PubMed ID: 12580810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cell function and number of peripheral blood are not altered in recurrent aphthous ulceration.
    Pedersen A; Pedersen BK
    Oral Surg Oral Med Oral Pathol; 1993 Nov; 76(5):616-9. PubMed ID: 7504229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose interleukin-2 in combination with interferon-alpha effectively modulates biological response in vivo.
    Schneekloth C; Körfer A; Hadam M; Lopez Hänninen E; Menzel T; Schomburg A; Dallmann I; Kirchner H; Poliwoda H; Atzpodien J
    Acta Haematol; 1993; 89(1):13-21. PubMed ID: 7683166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basic fibroblast growth factor and interleukins 4 and 6 stimulate the release of IFN-gamma by individual NK cells.
    Lewis CE; Ramshaw AL; Lorenzen J; McGee JO
    Cell Immunol; 1991 Jan; 132(1):158-67. PubMed ID: 1829652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM; Robertson MJ; Levine H; Manley TJ; Schow PW; Ritz J
    Eur J Immunol; 1992 Jan; 22(1):1-6. PubMed ID: 1370410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection.
    Lucas M; Gadola S; Meier U; Young NT; Harcourt G; Karadimitris A; Coumi N; Brown D; Dusheiko G; Cerundolo V; Klenerman P
    J Virol; 2003 Feb; 77(3):2251-7. PubMed ID: 12525661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human natural killer cell committed thymocytes and their relation to the T cell lineage.
    Sánchez MJ; Spits H; Lanier LL; Phillips JH
    J Exp Med; 1993 Dec; 178(6):1857-66. PubMed ID: 7504051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells.
    Vivier E; Sorrell JM; Ackerly M; Robertson MJ; Rasmussen RA; Levine H; Anderson P
    J Exp Med; 1993 Dec; 178(6):2023-33. PubMed ID: 7504054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Gillio A
    Cell Immunol; 1990 Mar; 126(1):211-26. PubMed ID: 1689220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification of lymphoproliferative disorder of granular lymphocytes.
    Wong KF; Chan JK
    Arch Pathol Lab Med; 1993 Mar; 117(3):233-4. PubMed ID: 7680193
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenotypic analysis of PBMCs from uterine cervix cancer patients with high natural killer activity.
    Pinel MI; Pires V; Harab RC; Rumjanek VM
    J Clin Lab Immunol; 1997; 49(2):83-9. PubMed ID: 9819676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.